MEMMAT
Phase 2 Recruiting
232 enrolled
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase 2 Terminated
5 enrolled
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Phase 2 Completed
178 enrolled 23 charts
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
Phase 2 Completed
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Completed
18 enrolled
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
Phase 3 Completed
332 enrolled
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Phase 1 Completed
17 enrolled
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
Phase 2 Completed
44 enrolled
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2 Completed
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
Phase 2 Completed
15 enrolled 9 charts
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
Phase 2 Completed
101 enrolled 10 charts
ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors
Phase 2 Completed
50 enrolled
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
Phase 2 Completed
50 enrolled
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
Phase 2 Completed
78 enrolled 7 charts
Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
Phase 2 Completed
26 enrolled
Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas
Phase 2 Completed
7 enrolled 8 charts
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
Phase 1 Completed
10 enrolled
Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
Phase 2 Unknown
40 enrolled